Browsing Category
Pharma Industry News
4744 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
How oral obesity drugs are changing treatment access: A look at semaglutide, amycretin, and orforglipron
Oral GLP-1 drugs like semaglutide, amycretin, and orforglipron are redefining obesity care. Explore trial data, payer impact, and what’s ahead for access and scale.
What is gold nanorod therapy and how does Sona Nanotech plan to use it to treat late-stage melanoma patients?
Sona Nanotech’s gold nanorod cancer therapy is heading to human trials. Learn how its CTAB-free Targeted Hyperthermia Therapy works and what’s next for melanoma care.
Bristol Myers Squibb Gains U.S. FDA Approval to Remove REMS Programs and Ease Monitoring Rules for Breyanzi and Abecma Cell Therapies
Bristol Myers Squibb gains U.S. FDA approval to remove REMS and reduce monitoring for Breyanzi and Abecma cell therapies, expanding access for blood cancer patients.
Piramal Pharma Solutions launches $90m U.S. expansion to boost sterile injectables and ADC manufacturing
Piramal Pharma Solutions invests $90 million to expand sterile injectables and ADC production in the U.S., positioning itself for major growth.
Aurinia Pharmaceuticals to present AUR200 Phase 1 trial data on June 30, 2025 in key webcast update
Aurinia Pharmaceuticals will release AUR200 Phase 1 results on June 30, 2025. Analysts await autoimmune insights. Join the webcast for full trial data.
Can Dr. Reddy’s PSAI business quietly power its next phase of global pharmaceutical growth?
Can Dr. Reddy’s PSAI division unlock global API and CDMO growth? Explore revenues, strategy, investor sentiment, and vertical integration outlook in 2025.
XtalPi and Pfizer deepen AI-powered drug discovery alliance with enhanced molecular modeling platform for small molecule breakthroughs
XtalPi expands collaboration with Pfizer to build high-throughput AI-driven molecular modeling platform for small molecule discovery. Read the full strategic update.
Schrödinger earns FDA Fast Track for SGR-1505 in Waldenström macroglobulinemia amid rising therapeutic demand
Schrödinger’s SGR-1505 receives FDA Fast Track designation for Waldenström macroglobulinemia, highlighting a novel MALT1-targeted approach.
STEMCELL Technologies launches STEMprep system to automate tissue dissociation in cancer and immunology research
STEMCELL Technologies has launched the STEMprep Tissue Dissociator System to automate and standardize tissue processing in cancer and immunology research.
Bone Biologics files new U.S. patent for NELL-1-based bone regeneration in spinal fusion
Bone Biologics files U.S. patent for rhNELL-1 bone regeneration in spine fusion, expanding IP ahead of clinical development. Learn what it means for investors.